Evidence map›Paper›PMID 21407828›Full record

ArticlePloS one2011

Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism.

Carmen Fiuza-Luces, Jonatan R Ruiz, Gabriel Rodríguez-Romo, Catalina Santiago, Félix Gómez-Gallego, Thomas Yvert, Amalia Cano-Nieto, Nuria Garatachea, María Morán, Alejandro Lucia

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Skeletal Muscle Expression of Actinin-3 (Frontiers in genetics · 2022
    Article
  6. Article
  7. Muscular Strength and Quality of Life in Older Adults: The Role ofInternational journal of environmental research and public health · 2021
    Article
  8. Effect ofSports (Basel, Switzerland) · 2020
    Article
  9. Frontiers in genetics · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Do olympic athletes train as in the Paleolithic era?Sports medicine (Auckland, N.Z.) · 2013
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Carmen Fiuza-LucesUniversidad Europea de Madrid, Madrid, Spain.
Jonatan R Ruiz
Gabriel Rodríguez-Romo
Catalina Santiago
Félix Gómez-Gallego
Thomas Yvert
Amalia Cano-Nieto
Nuria Garatachea
María Morán
Alejandro Lucia
Universidad Europea de Madrid · ESCentre for Biomedical Network Research on Rare Diseases · ESKarolinska Institutet · SEUniversidad de Zaragoza · ESUniversidad Politécnica de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise phenotypes have played a key role for ensuring survival over human evolution. We speculated that some genetic variants that influence exercise phenotypes could be associated with exceptional survival (i.e. reaching ≥100 years of age). Owing to its effects on muscle structure/function, a potential candidate is the Arg(R)577Ter(X) polymorphism (rs1815739) in ACTN3, the structural gene encoding the skeletal muscle protein α-actinin-3. We compared the ACTN3 R577X genotype/allele frequencies between the following groups of ethnically-matched (Spanish) individuals: centenarians (cases, n = 64; 57 female; age range: 100-108 years), young healthy controls (n = 283, 67 females, 216 males; 21±2 years), and humans who are at the two end-points of exercise capacity phenotypes, i.e. muscle endurance (50 male professional road cyclists) and muscle power (63 male jumpers/sprinters). Although there were no differences in genotype/allele frequencies between centenarians (RR:28.8%; RX:47.5%; XX:23.7%), and controls (RR:31.8%; RX:49.8%; XX:18.4%) or endurance athletes (RR:28.0%; RX:46%; XX:26.0%), we observed a significantly higher frequency of the X allele (P = 0.019) and XX genotype (P = 0.011) in centenarians compared with power athletes (RR:47.6%; RX:36.5%;XX:15.9%). Notably, the frequency of the null XX (α-actinin-3 deficient) genotype in centenarians was the highest ever reported in non-athletic Caucasian populations. In conclusion, despite there were no significant differences with the younger, control population, overall the ACTN3 genotype of centenarians resembles that of world-class elite endurance athletes and differs from that of elite power athletes. Our preliminary data would suggest a certain 'survival' advantage brought about by α-actinin-3 deficiency and the 'endurance'/oxidative muscle phenotype that is commonly associated with this condition.

Indexed as

AllelesActininAdultAged, 80 and overAmino Acid SubstitutionCohort StudiesFemaleGenotypeHumansMalePhysical EndurancePolymorphism, Single NucleotideYoung AdultActininACTN3 protein, human

Identifiers

PMID21407828
PMCPMC3048287
OpenAlexW2052717860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.